CATALYST PHARMACEUTICALS, INC. 8-K

What Happened

• On May 11, 2026, Catalyst Pharmaceuticals, Inc. (CPRX) filed a Form 8-K (Item 8.01) and issued a press release announcing its results of operations for the three months ended March 31, 2026 and providing a business update. The press release is attached to the 8-K as Exhibit 99.1.

Key Details

• Filing date: May 11, 2026; reporting period: quarter ended March 31, 2026.
• Item reported: 8.01 (Other Events) — press release announcing quarterly results and business update.
• Exhibit included: 99.1 — the press release with the results and update (details are in that exhibit).

Why It Matters

• The press release contains the company’s latest quarterly financial results and operational update that investors use to evaluate performance and near-term prospects. Review Exhibit 99.1 for revenue, net income (or loss), and any items such as changes in guidance, product performance, or pipeline progress that could affect the stock or investment thesis.